Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $987.27 | 71 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $196.89 | 11 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $177.26 | 10 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $124.50 | 18 | $0 (2017) |
| Shire North American Group Inc | $63.72 | 4 | $0 (2019) |
| Depomed, Inc. | $58.31 | 4 | $0 (2017) |
| Amgen Inc. | $46.06 | 3 | $0 (2023) |
| ARBOR PHARMACEUTICALS, INC. | $43.74 | 3 | $0 (2019) |
| PFIZER INC. | $34.78 | 2 | $0 (2024) |
| Amarin Pharma Inc. | $32.69 | 2 | $0 (2021) |
| Orthogenrx Inc. | $28.81 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.78 | 2 | PFIZER INC. ($34.78) |
| 2023 | $55.60 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($37.76) |
| 2022 | $29.80 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($18.02) |
| 2021 | $159.87 | 10 | Novo Nordisk Inc ($69.23) |
| 2020 | $289.08 | 16 | Novo Nordisk Inc ($127.66) |
| 2019 | $87.44 | 6 | Shire North American Group Inc ($33.44) |
| 2018 | $62.50 | 4 | ARBOR PHARMACEUTICALS, INC. ($32.50) |
| 2017 | $268.20 | 28 | BioDelivery Sciences International, Inc. ($124.50) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/14/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Inflammation | ||||||
| 03/28/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 02/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | Avion Pharmaceuticals | Balcoltra (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Oral Contraceptive | ||||||
| 09/30/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Obesity | ||||||
| 09/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiovascular | ||||||
| 06/24/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Obesity | ||||||
| 05/17/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Obesity | ||||||
| 02/09/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Obesity | ||||||
| 02/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Obesity | ||||||
| 11/11/2020 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $20.61 | General |
| 10/22/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular | ||||||
| 09/28/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Obesity | ||||||
| 09/09/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Obesity | ||||||
| 08/20/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Thomas Bond, MD
Dr. Thomas Bond, MD is a Sports Medicine healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194752592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Bond, MD has received a total of $987.27 in payments from pharmaceutical and medical device companies, with $34.78 received in 2024. These payments were reported across 71 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($987.27).
Practice Information
- Specialty Sports Medicine
- Location Lafayette, LA
- Active Since 06/28/2006
- Last Updated 03/07/2023
- Taxonomy Code 207QS0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194752592
Products in Payments
- Saxenda (Drug) $168.87
- VYVANSE (Drug) $152.66
- BUNAVAIL 2.1 mg 30-count box (Drug) $124.50
- Nucynta (Drug) $58.31
- TRINTELLIX (Drug) $53.92
- Horizant (Drug) $43.74
- ELIQUIS (Drug) $34.78
- Vascepa (Drug) $32.69
- GenVisc 850 (Device) $28.81
- Aimovig (Biological) $28.22
- Wegovy (Drug) $28.02
- AMITIZA (Drug) $20.48
- NEOX (Biological) $18.82
- Aemcolo (Drug) $17.97
- Otezla (Drug) $17.84
- Adzenys XR-ODT (Drug) $17.16
- XTAMPZAER (Drug) $15.73
- Balcoltra (Drug) $14.74
- Daraprim (Drug) $14.04
- MYDAYIS (Drug) $13.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Lafayette
Dr. Daniel Daluga, Md, MD
Sports Medicine — Payments: $43,868
Dr. Paul Rodenhouse, Do, DO
Sports Medicine — Payments: $19,417
Emily Krodel, Md, MD
Sports Medicine — Payments: $2,570
Dr. Thomas Montgomery, M.d, M.D
Sports Medicine — Payments: $2,223
Dr. Peter Seymour, Peter Seymour D.o, PETER SEYMOUR D.O
Sports Medicine — Payments: $2,175
Dr. Amanda Phillips, Md, MD
Sports Medicine — Payments: $753.25